# Not All Tests Are Created Equal Galaxy Diagnostics was founded to solve one of medicine’s toughest challenges: Detecting stealth pathogens that evade traditional diagnostics. What began with **_Bartonella_** has grown into a broader mission, bringing clarity to complex cases and expanding detection across more elusive pathogens. [learn more about our research](/content/why-galaxy/our-research/index.html) [Explore Testing Solutions](/content/for-providers/index.html) ## We’re Scientists First—And Still Leading the Way Our roots are in _Bartonella_ research, where we helped pioneer direct detection methods for low abundance pathogens. Today, we bring that same scientific rigor the detection of _Babesia_ and other complex, elusive pathogens. - 450+ peer-reviewed publications - Groundbreaking work in stealth pathogen detection - Trusted by clinicians treating chronic, complex conditions ## From Results to Real Decisions We don’t just generate results. We empower providers to: - Diagnose with precision - Treat with confidence - Deliver care backed by science Diagnostics built for real-world clinical action. “A lot of patients come into our office who have been treated for Tickborne Illness but still have debilitating symptoms. It is often difficult to determine if persistent Lyme, other co-infections, or immune dysregulation are causing their issues. I use Nanotrap to discern the root cause so patients can get the targeted treatments they need.” —Dr Chris Turnpaugh, Turnpaugh Health and Wellness ### Diagnostics Designed for the Complexity of Stealth Infections Galaxy’s platform integrates both direct and indirect detection methods, giving providers the flexibility to diagnose with accuracy at any stage of infection. #### Digital PCR Offers up to **10x the sensitivity** of standard PCR, detecting _Borrelia_, _Babesia,_ and _Bartonella_ at the genus level to deliver earlier insights in complex cases. 1 #### Urine Testing Detects Lyme _Borrelia_ in the early stages, **without relying on an antibody** response and helps determine ongoing infection in chronically ill patients. #### Bartonella IFA Panel Covers **four clinically relevant** species: _B. henselae, B. vinsonii berkhoffii, B. quintana,_ and _B. koehlerae._ [View Our Tests & Technology](/content/tests-technology/index.html) 1 Maggi RG, Calchi AC, Moore CO, Kingston E, Breitschwerdt EB. Human Babesia odocoilei and Bartonellaspp. co-infections in the Americas. Parasit Vectors. 2024;17(1):302. doi:10.1186/s13071-024-06385-4 ### Who We Serve #### For Functional & Integrative Providers Overwhelmed by conflicting test claims? We offer **clear education and clinical guidance**, so you can grow confidence while supporting complex patients. #### For Data-Driven Decision-Makers You need tools you can trust and data that holds up. Galaxy delivers **high-sensitivity diagnostics backed by transparent** science, where assay development, rigorous validation, and reproducibility are clearly defined. #### For Busy Primary Care Providers Your patients want answers. Galaxy makes it easy to order, ship, and get **clear results, with responsive support** when questions arise. ### The Values Behind Every Test We Build ###### Scientific Excellence We lead with data, transparency, and peer-reviewed publications. ###### Transparency From methodology to results,
 we stand behind our science. ###### Evidence-Based Innovation We bring new tools to market with clinical relevance and credibility. ###### Trusted Ally We walk alongside you not just delivering results, but helping you act on them. ## Ready to Bring Clarity to Complex Cases? [learn more about our research](/content/why-galaxy/our-research/index.html) [Explore Testing Solutions](/content/for-providers/index.html) [Start Testing Today](/content/create-an-account/index.html)